Vincent Lavelle

Large-scale AI-Ready Data for Anti-Cancer Drug Response Modeling

This work substantially expand the IMPROVE benchmark through large-scale integration of pharmacogenomic data, primarily from PharmacoDB, together with additional smaller data sources, which includes millions of drug response measurements, broader multi-omics coverage, and a major increase in chemical diversity, adding more than 50,000 compounds.